<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:47:48Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/15008" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/15008</identifier><datestamp>2026-10-18T21:14:22Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Estimation of the prevalence and distribution of HPV genotypes and identification of related risk factors among Turkish women</dc:title><dc:creator>Kulhan, Mehmet</dc:creator><dc:creator>Kulhan, Nur G.</dc:creator><dc:creator>Seven, Yasemin</dc:creator><dc:creator>Nayki, Umit A.</dc:creator><dc:creator>Nayki, Cenk</dc:creator><dc:creator>Ata, Nahit</dc:creator><dc:creator>Ulug, Pasa</dc:creator><dc:subject>Cervical smears</dc:subject><dc:subject>HPV genotyping</dc:subject><dc:subject>Human papillomavirus DNA tests</dc:subject><dc:subject>adult</dc:subject><dc:subject>Article</dc:subject><dc:subject>cancer screening</dc:subject><dc:subject>controlled study</dc:subject><dc:subject>female</dc:subject><dc:subject>human</dc:subject><dc:subject>Human papillomavirus type 16</dc:subject><dc:subject>Human papillomavirus type 18</dc:subject><dc:subject>Human papillomavirus type 31</dc:subject><dc:subject>Human papillomavirus type 33</dc:subject><dc:subject>Human papillomavirus type 35</dc:subject><dc:subject>Human papillomavirus type 39</dc:subject><dc:subject>Human papillomavirus type 40</dc:subject><dc:subject>Human papillomavirus type 42</dc:subject><dc:subject>Human papillomavirus type 43</dc:subject><dc:subject>Human papillomavirus type 44</dc:subject><dc:subject>Human papillomavirus type 45</dc:subject><dc:subject>Human papillomavirus type 51</dc:subject><dc:subject>Human papillomavirus type 52</dc:subject><dc:subject>Human papillomavirus type 53</dc:subject><dc:subject>Human papillomavirus type 54</dc:subject><dc:subject>Human papillomavirus type 56</dc:subject><dc:subject>Human papillomavirus type 58</dc:subject><dc:subject>Human papillomavirus type 59</dc:subject><dc:subject>Human papillomavirus type 61</dc:subject><dc:subject>Human papillomavirus type 68</dc:subject><dc:subject>Human papillomavirus type 72</dc:subject><dc:description>Aim of the study: The present study aims to estimate the prevalence and distribution of HPV genotypes and identify related risk factors among Turkish women. Material and methods: 11 624 Turkish women attending our gynaecological clinic and expressing a desire for access to cervical cancer screening were assessed during the years 2014-2016. Cervical specimens were collected and transported using the HC2 HPV DNA Collection Device (consisting of a cervical brush and digene Specimen Transport Medium). Results: Among these 11 624 individuals, positive HPV test results were obtained for 325 (2.79%), and negative results were observed for 11 299 (97.2%). The vast majority of patients were between the 3rd and 5th decades and the mean age of the patients was 44 ±9.12 (range 27-66). Among the HPV-positive women, 205 were positive for a single HPV type (205/325 = 63.1% of HPV infections; 205/11624 = 1.76% of all samples) and 120 were positive for multiple types (120/325 = 36.9% of HPV infections; 120/11624 = 1.03% of all samples). The four most prevalent high-risk types were HPV 16, 31, 51 and 52, with frequencies of 11.25%, 7.83%, 6.06% and 3.16%, respectively. Conclusions: There appears to be geographic variation in the distribution of HPV genotypes. In this study, the four most prevalent high-risk types were HPV 16, 31, 51 and 52, with frequencies of 11.25%, 7.83%, 6.06% and 3.16%, respectively.</dc:description><dc:publisher>Termedia Publishing House Ltd.</dc:publisher><dc:date>2017</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/15008</dc:identifier><dc:identifier>https://doi.org/10.5114/wo.2017.69591</dc:identifier><dc:identifier>1428-2526</dc:identifier><dc:language>en</dc:language><dc:relation>Wspolczesna Onkologia</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/15008</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>